ENDOCANNABINOIDS: A THERAPEUTIC OPTION TO CANCER TREATMENT

Scientific advances in Chemistry and Medicine now study wise ancestral popular usages of natural resources. Cannabis sativa>/I> has been traditionally used for medicinal and recreational purposes. However, its important psychoactive effects limit its use. Some governments allow its controlled...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Fabio MAYORGA N., Rosa H. CÁRDENAS S.
Formato:	article
Lenguaje:	EN
Publicado:	Universidad de Antioquia 2009
Materias:	endocannabinoids anandamide receptors CB<sub>1</sub> y CB<sub>2</sub> cancer. Food processing and manufacture TP368-456 Pharmaceutical industry HD9665-9675
Acceso en línea:	https://doaj.org/article/35f94445d3914686b4ba11d1e5a0e99d
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:35f94445d3914686b4ba11d1e5a0e99d
record_format	dspace
spelling	oai:doaj.org-article:35f94445d3914686b4ba11d1e5a0e99d2021-11-19T04:15:16ZENDOCANNABINOIDS: A THERAPEUTIC OPTION TO CANCER TREATMENT0121-40042145-2660https://doaj.org/article/35f94445d3914686b4ba11d1e5a0e99d2009-07-01T00:00:00Zhttps://revistas.udea.edu.co/index.php/vitae/article/view/1963https://doaj.org/toc/0121-4004https://doaj.org/toc/2145-2660Scientific advances in Chemistry and Medicine now study wise ancestral popular usages of natural resources. Cannabis sativa>/I> has been traditionally used for medicinal and recreational purposes. However, its important psychoactive effects limit its use. Some governments allow its controlled use for medicinal purposes since the discovery of endogenous compounds with similar properties to cannabinoids (endocannabinoids) combined with the previous knowledge on CB1 and CB2 receptors on which they act. A great interest to discover new therapeutic substances for several pathologies treatment has grown increasingly the world over. The possibilities to take advantage of the endocannabinoids structures to design new molecules with antineoplastic activity are coming closer to this challenge, which looks for new efficient drugs like those used today, but less toxic. Knowledge of the molecular aspects of many of these compounds as well as the biochemical ways on which such compounds act, attract now more interest everywhere. Fabio MAYORGA N.Rosa H. CÁRDENAS S.Universidad de Antioquiaarticleendocannabinoidsanandamidereceptors CB<sub>1</sub> y CB<sub>2</sub>cancer.Food processing and manufactureTP368-456Pharmaceutical industryHD9665-9675ENVitae, Vol 16, Iss 2 (2009)
institution	DOAJ
collection	DOAJ
language	EN
topic	endocannabinoids anandamide receptors CB<sub>1</sub> y CB<sub>2</sub> cancer. Food processing and manufacture TP368-456 Pharmaceutical industry HD9665-9675
spellingShingle	endocannabinoids anandamide receptors CB<sub>1</sub> y CB<sub>2</sub> cancer. Food processing and manufacture TP368-456 Pharmaceutical industry HD9665-9675 Fabio MAYORGA N. Rosa H. CÁRDENAS S. ENDOCANNABINOIDS: A THERAPEUTIC OPTION TO CANCER TREATMENT
description	Scientific advances in Chemistry and Medicine now study wise ancestral popular usages of natural resources. Cannabis sativa>/I> has been traditionally used for medicinal and recreational purposes. However, its important psychoactive effects limit its use. Some governments allow its controlled use for medicinal purposes since the discovery of endogenous compounds with similar properties to cannabinoids (endocannabinoids) combined with the previous knowledge on CB1 and CB2 receptors on which they act. A great interest to discover new therapeutic substances for several pathologies treatment has grown increasingly the world over. The possibilities to take advantage of the endocannabinoids structures to design new molecules with antineoplastic activity are coming closer to this challenge, which looks for new efficient drugs like those used today, but less toxic. Knowledge of the molecular aspects of many of these compounds as well as the biochemical ways on which such compounds act, attract now more interest everywhere.
format	article
author	Fabio MAYORGA N. Rosa H. CÁRDENAS S.
author_facet	Fabio MAYORGA N. Rosa H. CÁRDENAS S.
author_sort	Fabio MAYORGA N.
title	ENDOCANNABINOIDS: A THERAPEUTIC OPTION TO CANCER TREATMENT
title_short	ENDOCANNABINOIDS: A THERAPEUTIC OPTION TO CANCER TREATMENT
title_full	ENDOCANNABINOIDS: A THERAPEUTIC OPTION TO CANCER TREATMENT
title_fullStr	ENDOCANNABINOIDS: A THERAPEUTIC OPTION TO CANCER TREATMENT
title_full_unstemmed	ENDOCANNABINOIDS: A THERAPEUTIC OPTION TO CANCER TREATMENT
title_sort	endocannabinoids: a therapeutic option to cancer treatment
publisher	Universidad de Antioquia
publishDate	2009
url	https://doaj.org/article/35f94445d3914686b4ba11d1e5a0e99d
work_keys_str_mv	AT fabiomayorgan endocannabinoidsatherapeuticoptiontocancertreatment AT rosahcardenass endocannabinoidsatherapeuticoptiontocancertreatment
_version_	1718420453851136000

ENDOCANNABINOIDS: A THERAPEUTIC OPTION TO CANCER TREATMENT

Ejemplares similares